Boca Oncology Partners (Tables) (BOP and BOPRE [Member])

3 Months Ended

Mar. 31, 2014

BOP and BOPRE [Member]

Schedule of Equity Method Investments [Line Items]

Proceeds from the sale of BOP

The Company's proceeds from the sale of BOP were allocated as follows:

Proceeds from sale	$	407,000
Payoff of loans to BOP		202,000
Net proceeds	$	205,000
Less:  Investment in BOP		-
Gain from sale	$	205,000

Summarized Financial Information

The following tables present the summarized financial information of BOP and BOPRE:

BOP Condensed Income Statement Information

	Three Months Ended
	March 31,
	2014			2013
Patient revenue	$	115,000		$	519,000
Net income	$	(108,000	)	$	13,000
USNC's equity in (loss) income in BOP	$	(12,000	)	$	1,000

BOP Condensed Balance Sheet Information

	March 31,		December 31,
	2014		2013
Current assets	$	-	$	640,000
Noncurrent assets		-		1,831,000
Total assets	$	-	$	2,471,000
Current liabilities	$	-	$	730,000
Noncurrent liabilities		-		2,126,000
Equity		-		(385,000	)
Total liabilities and equity	$	-	$	2,471,000

BOPRE Condensed Income Statement Information

	Three Months Ended
	March 31,
	2014		2013
Rental Income	$	-	$	-
Net income (loss)	$	-	$	-
USNC's equity in income in BOPRE	$	-	$	-

BOPRE Condensed Balance Sheet Information

	March 31,		December 31,
	2014		2013
Current assets	$	103,000	$	132,000
Noncurrent assets		736,000		707,000
Total assets	$	839,000	$	839,000
Current liabilities	$	-	$	-
Noncurrent liabilities		-		-
Equity		839,000		839,000
Total liabilities and equity	$	839,000	$	839,000